Global and China Penicillin Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

Penicillin refers to a class of antibiotics containing penicillin in the molecule, which can destroy the cell wall of bacteria and play a bactericidal role in the breeding period of bacterial cells. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects.
Market competition is intense. CSPC Zhongrun, United Laboratories, Novartis (Sandoz Anti-Infectives), Huaxing Pharma, North China Pharmaceutical, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 14 manufacturers hold nearly 90% market share in 2019.

Market Analysis and Insights: Global and China Penicillin Active Pharmaceutical Ingredients Market
This report focuses on global and China Penicillin Active Pharmaceutical Ingredients market.
In 2020, the global Penicillin Active Pharmaceutical Ingredients market size was US$ 2543 million and it is expected to reach US$ 3433.5 million by the end of 2027, with a CAGR of 4.4% during 2021-2027. In China the Penicillin Active Pharmaceutical Ingredients market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Penicillin Active Pharmaceutical Ingredients Scope and Market Size
Penicillin Active Pharmaceutical Ingredients market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Penicillin Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Penicillin Active Pharmaceutical Ingredients market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Penicillin G Potassium
Ampicillin
Piperacillin
Sulbactam Sodium
Tazobactam
Clavulanic Acid
Amoxicillin
The proportion of penicillin G potassium in 2019 is about 64.85%.

Segment by Application
For Oral
For Injection
Penicillin active pharmaceutical ingredients is widely for oral and injection. The proportion of oral in 2019 is about 62.70%.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Centrient Pharmaceuticals
Jiangxi Fushine Pharmaceutical
Kelun
Harbin Pharmaceutical Group
Changzhou RedSun
Jiangxi Huabang
LKPC
Huaxing Pharma
North China Pharmaceutical
Qilu Tianhe Pharma
Novartis (Sandoz Anti-Infectives)
CSPC Zhongrun
United Laboratories
Sinopharm Weiqida Pharmaceutical